Trade BBLG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bone Biologics Corp (BBLG) is trading at US$0.52, up 3.82% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.73M. Over the past 52 weeks, BBLG has traded between US$0.43 and US$2.89. On Syfe you can trade BBLG with $0 commission and add it to your watchlist.
| Previous close | US$0.50 |
|---|---|
| Market cap | US$1.73M |
| 52-week range | US$0.43 – US$2.89 |
| Volume | 109.58K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bone Biologics Corp
Bone Biologics Corp. operates as a medical device company. It engages in the research and development of bone regeneration in spinal fusion. The firm's core product is NELL-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
Year: 2015
Bone Biologics Prices Up to $9 Million Private Placement of Stock, Warrants
Jul 8, 10:00 AM · MT Newswires
Bone Biologics Corp (BBLG) stock is trading at US$0.52, +3.82% from the previous close of US$0.50.
The market cap for Bone Biologics Corp (BBLG) stock is approximately US$1.73M.
The 52-week high for Bone Biologics Corp (BBLG) stock is US$2.89.
The 52-week low for Bone Biologics Corp (BBLG) stock is US$0.43.
Bone Biologics Corp (BBLG) does not currently pay a dividend.
Stay on top of BBLG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
